Update on the Role of Rifaximin in Digestive Diseases.

Dumitrascu, Dan Lucian; Bakulin, Igor; Berzigotti, Annalisa; Cravo, Marília; Gombošová, Laura; Lukas, Milan; Pietrzak, Anna; Remes-Troche, José María; Romero-Gómez, Manuel; Balmori, Mercedes Amieva; Gonçalves, Tiago Cúrdia; Hamzaoui, Lamine; Juricek, Radovan; Moreira, Leticia; Neubauer, Katarzyna; Surdea-Blaga, Teodora; Tikhonov, Igor N; Trna, Jan; Ianiro, Gianluca; Ponziani, Francesca Romana; ... (2023). Update on the Role of Rifaximin in Digestive Diseases. Journal of gastrointestinal and liver diseases, 32(1), pp. 92-109. "Editura Medicală Universitară "Iuliu Haţieganu" 10.15403/jgld-4871

[img] Text
document-2.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (290kB) | Request a copy

Various environmental factors affecting the human microbiota may lead to gut microbial imbalance and to the development of pathologies. Alterations of gut microbiota have been firmly implicated in digestive diseases such as hepatic encephalopathy, irritable bowel syndrome and diverticular disease. However, while these three conditions may all be related to dysfunction of the gut-liver-brain axis, the precise pathophysiology appears to differ somewhat for each. Herein, current knowledge on the pathophysiology of hepatic encephalopathy, irritable bowel syndrome, and diverticular disease are reviewed, with a special focus on the gut microbiota modulation associated with these disorders during therapy with rifaximin. In general, the evidence for the efficacy of rifaximin in hepatic encephalopathy appears to be well consolidated, although it is less supported for irritable bowel syndrome and diverticular disease. We reviewed current clinical practice for the management of these clinical conditions and underlined the desirability of more real-world studies to fully understand the potential of rifaximin in these clinical situations and obtain even more precise indications for the use of the drug.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Berzigotti, Annalisa

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1841-8724

Publisher:

"Editura Medicală Universitară "Iuliu Haţieganu"

Language:

English

Submitter:

Pubmed Import

Date Deposited:

03 Apr 2023 12:43

Last Modified:

03 Apr 2023 12:52

Publisher DOI:

10.15403/jgld-4871

PubMed ID:

37004222

BORIS DOI:

10.48350/181394

URI:

https://boris.unibe.ch/id/eprint/181394

Actions (login required)

Edit item Edit item
Provide Feedback